Enpath CE-marks sheath:
This article was originally published in Clinica
Executive Summary
Paving the way for a launch into the European electrophysiology (EP) market, Enpath Medical has CE-marked its steerable sheath, which is designed to facilitate the placement of interventional devices in the peripheral, coronary and neurovascular systems. The product features distal tip deflection to aid in the precise placement of such devices as cardiac ablation catheters and peripheral stent delivery catheters, said the Plymouth, Minnesota firm. It is being launched in Europe for EP applications by Enpath's distribution partner Bard Electrophysiology, a division of CR Bard. The device was cleared in the US in July 2005.